Childhood Cancer

Boston, Massachusetts, USA | July 16, 2026 Dana-Farber Cancer Institute researchers have identified CDK8 as a promising therapeutic target...

Oxford, UK and Cleveland, Ohio, US, July 1, 2026 The Oxford-Harrington Rare Disease Centre (OHC) has announced a major...

RALEIGH, North Carolina, USA & TEL AVIV, Israel – June 9, 2026 RedHill Biopharma has received a significant regulatory...